Share on StockTwits

BTG plc (LON:BTG)‘s stock had its “overweight” rating reaffirmed by research analysts at JPMorgan Chase & Co. in a report released on Tuesday. They currently have a GBX 630 ($10.69) target price on the stock. JPMorgan Chase & Co.’s price target would suggest a potential upside of 4.91% from the stock’s previous close.

BTG plc (LON:BTG) traded up 0.08% on Tuesday, hitting GBX 600.50. The stock had a trading volume of 594,225 shares. BTG plc has a 52-week low of GBX 353.10 and a 52-week high of GBX 630.64. The stock’s 50-day moving average is GBX 570. and its 200-day moving average is GBX 572.5. The company’s market cap is £2.167 billion.

Several other analysts have also recently commented on the stock. Analysts at Jefferies Group reiterated a “hold” rating on shares of BTG plc in a research note on Thursday, June 5th. They now have a GBX 525 ($8.91) price target on the stock. Separately, analysts at FinnCap reiterated a “sell” rating on shares of BTG plc in a research note on Wednesday, June 4th. They now have a GBX 345 ($5.86) price target on the stock. Finally, analysts at Nplus1 Brewin reiterated a “sell” rating on shares of BTG plc in a research note on Tuesday, May 27th. They now have a GBX 486 ($8.25) price target on the stock. Three research analysts have rated the stock with a sell rating, two have issued a hold rating and five have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of GBX 546.67 ($9.28).

BTG plc is an international specialist healthcare company. The Company is focused on three business areas: Specialty Pharmaceuticals, Interventional Medicine and Licensing & Biotechnology.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.